兆驰股份: 关于出售处置资产的进展暨关联交易的公告

Core Viewpoint - The company has decided to extend the repayment period for the transfer of receivables to Nanchang Zhaotou until December 31, 2027, with no interest charged for repayments made within the agreed period, while interest will be charged on any outstanding balance after the extension period [1][16][17]. Summary by Sections 1. Overview of Related Transactions - The company is involved in a related transaction with Nanchang Zhaotou and Mr. Guo Wei, which includes the transfer of receivables related to debts owed by Evergrande Group and its affiliates [2][10]. - The transaction was approved in previous board and shareholder meetings, with a total transaction price of RMB 2 billion, of which RMB 1 billion has been received [2][3]. 2. Progress of the Transaction - As of the announcement date, the total amount owed by Nanchang Zhaotou to the company, including principal and interest, is RMB 2,367.52 million, with RMB 1,265.52 million already repaid [6][11]. - The company has agreed to extend the repayment deadline for the receivables to December 31, 2027, with specific terms regarding interest on unpaid amounts after this date [6][12]. 3. Main Content of the Related Transaction - The repayment plan includes that any repayments made by Nanchang Zhaotou during the extension period will not incur interest, while interest will be charged on any remaining balance after the extension [11][12]. - The repayment sources include dividends from the company and its subsidiaries, as well as proceeds from the disposal of assets related to the transaction [7][12]. 4. Purpose of the Transaction and Impact on the Company - The transaction aims to mitigate risks associated with the company's receivables from Evergrande and to ensure the stability of the company's operations while protecting shareholder interests [15][16]. - The company believes that the adjustments to the transaction terms are reasonable and market-oriented, ensuring that the interests of all shareholders, especially minority shareholders, are not harmed [15][16]. 5. Independent Directors' Review - The independent directors have reviewed and approved the transaction, emphasizing that the adjustments are made to protect the company's and shareholders' interests [16][17].